Cumhur Aydemir
Research Subjects
Cumhur Aydemir has a total of 112 co-authors. Here are the top co-authors by number of shared publications:
- Omer Erdeve
Division of Neonatology, Department of Pediatrics, Ankara University School of Medicine, Ankara, Turkey
6 shared publications Ugur Dilmen
6 shared publicationsNilufer Eldes
4 shared publicationsNurdan Uras
4 shared publicationsSerife Suna Oguz
4 shared publicationsEbru Kolsal
3 shared publications
Latest Publications
- 18 May 2024
- Published by Wiley in Birth Defects Research
- Vol. 116 (5) , e2346
Radiosensitivity in a newborn with microcephaly: A case report of Nijmegen breakage syndrome
Aim: Nijmegen breakage syndrome (NBS) is an autosomal recessive DNA repair disorder which is characterized by immunodeficiency and increased risk of lymphoproliferative malignancy.Case: We observed an increase in the rate of chromosomal rearrangements in the cultured cells following an incidental radiograph for craniosynostosis in a newborn who was followed up due to microcephaly. We identified a homozygous deletion of c.657_661delACAAA/p.Lys219fs (rs587776650) in the NBN gene through whole exome sequencing.Conclusion: It is crucial to thoroughly examine the clinical features of newborns with microcephaly and consider chromosomal instability syndromes just like Nijmegen breakage syndrome. Not overlooking radiosensitivity, which is a characteristic feature of this syndrome, is a vital condition to the patient's survival time.
- 18 May 2024
- Published by Wiley in Birth Defects Research
- Vol. 116 (5) , e2346
Radiosensitivity in a newborn with microcephaly: A case report of Nijmegen breakage syndrome
Aim: Nijmegen breakage syndrome (NBS) is an autosomal recessive DNA repair disorder which is characterized by immunodeficiency and increased risk of lymphoproliferative malignancy.Case: We observed an increase in the rate of chromosomal rearrangements in the cultured cells following an incidental radiograph for craniosynostosis in a newborn who was followed up due to microcephaly. We identified a homozygous deletion of c.657_661delACAAA/p.Lys219fs (rs587776650) in the NBN gene through whole exome sequencing.Conclusion: It is crucial to thoroughly examine the clinical features of newborns with microcephaly and consider chromosomal instability syndromes just like Nijmegen breakage syndrome. Not overlooking radiosensitivity, which is a characteristic feature of this syndrome, is a vital condition to the patient's survival time.
- Open Access
- 31 August 2023
- Published by Bulent Evcevit University in Batı Karadeniz Tıp Dergisi
- Vol. 7 (2) , 112-119
Asymmetric Dimethyl Arginine and Oxidant/Antioxidant Level in Preeclamptic Mothers and Their Babies
Aim: It is thought that asymmetric dimethyl arginine(ADMA) level is significantly higher in pregnant women with preeclampsia compared to healthy pregnant women, ADMA elevation develops before the clinical signs of preeclampsia, and ADMA plays a role in the pathogenesis of preeclampsia. In this study, it was aimed to investigate whether serum ADMA, total nitrite and nitrate (NOx), arginine and total antioxidant capacity (TAC) and levels in placenta samples taken from healthy and preeclamptic pregnant women and their babies are associated with preeclampsia, whether preeclampsia can be detected beforehand with these markers, and whether possible problems that may develop in the mother and baby can be prevented as a result. Material and Methods: 62 pregnant women and their babies who were followed up in Zonguldak Bülent Ecevit University obstetrics service are divided two groups; 31 preeclamptic pregnant and babies (Group I), formed Patient group; 31 pregnant and babies without preeclampsia (Group II), formed Control Group. Blood samples were obtained from mothers before birth, from the cord during birth, from babies in first 24 hours after birth and placenta samples were obtained from each pregnant to evaluate in the study. Age, weight, initial pregnancy state, pregnancy period, systolic and diastolic blood pressure levels of mothers with and without pre-eclampsia diagnosis, while birth weights, genders, problems and complications during treatment process, clinic and laboratory properties, prognosis, ADMA, arginine, NOx and TAC levels of babies were examined in this study. Results: There was no significant difference between two groups about antenatal factors that effect on prognosis. In the comparison of blood values, ADMA level of preeclamptic group was significantly higher (p
- 31 August 2023
- Published by Bulent Evcevit University in Batı Karadeniz Tıp Dergisi
- Vol. 7 (2) , 112-119
Open AccessAsymmetric Dimethyl Arginine and Oxidant/Antioxidant Level in Preeclamptic Mothers and Their Babies
Aim: It is thought that asymmetric dimethyl arginine(ADMA) level is significantly higher in pregnant women with preeclampsia compared to healthy pregnant women, ADMA elevation develops before the clinical signs of preeclampsia, and ADMA plays a role in the pathogenesis of preeclampsia. In this study, it was aimed to investigate whether serum ADMA, total nitrite and nitrate (NOx), arginine and total antioxidant capacity (TAC) and levels in placenta samples taken from healthy and preeclamptic pregnant women and their babies are associated with preeclampsia, whether preeclampsia can be detected beforehand with these markers, and whether possible problems that may develop in the mother and baby can be prevented as a result. Material and Methods: 62 pregnant women and their babies who were followed up in Zonguldak Bülent Ecevit University obstetrics service are divided two groups; 31 preeclamptic pregnant and babies (Group I), formed Patient group; 31 pregnant and babies without preeclampsia (Group II), formed Control Group. Blood samples were obtained from mothers before birth, from the cord during birth, from babies in first 24 hours after birth and placenta samples were obtained from each pregnant to evaluate in the study. Age, weight, initial pregnancy state, pregnancy period, systolic and diastolic blood pressure levels of mothers with and without pre-eclampsia diagnosis, while birth weights, genders, problems and complications during treatment process, clinic and laboratory properties, prognosis, ADMA, arginine, NOx and TAC levels of babies were examined in this study. Results: There was no significant difference between two groups about antenatal factors that effect on prognosis. In the comparison of blood values, ADMA level of preeclamptic group was significantly higher (p
- 4 April 2023
- Published by Georg Thieme Verlag KG in Journal of Pediatric Infectious Diseases
- Vol. 18 (04) , 193-198
Evaluation of Changes in Leukocyte Surface Markers in the Early Diagnosis of Late-Onset Neonatal Sepsis
Objective This study aimed to evaluate the cluster of differentiation (CD)64, CD16, CD11b, CD63 human leukocyte antigen-DR (HLA-DR), and CD62L leukocyte surface marker abnormalities using flow cytometry in the early diagnosis of late-onset neonatal sepsis. Methods Forty-four neonates were included in this study. Of them, 22 neonates with clinical late-onset neonatal sepsis were included in the study group, and the remaining 22 neonates without sepsis were considered the control group. Complete sepsis screening was performed. Additionally, monocyte and neutrophil surfaces marker were examined using flow cytometry. Results The expression of the leukocyte surface markers CD16 and CD64 on monocytes and neutrophils was significantly higher in the study group than in the control group (p < 0.05), while the CD63, CD62L, CD11b, and HLA-DR levels were similar to those in the control group (p > 0.05). Furthermore, receiver operating characteristic curve analysis indicated that neutrophil CD64 (nCD64) is a diagnostic marker for neonatal sepsis, with an area under the curve of 0.901. The CD64 and CD16, which are the respective leukocyte surface markers on neutrophils and monocytes, are useful tests in the early diagnosis of late-onset neonatal sepsis. Conclusion In addition to acute phase proteins, cell surface antigens such as CD16 and more specifically CD64 should be used in routine investigations for the early diagnosis of late-onset neonatal sepsis. Such use in combination with acute phase reactants can improve diagnostic accuracy.
- 4 April 2023
- Published by Georg Thieme Verlag KG in Journal of Pediatric Infectious Diseases
- Vol. 18 (04) , 193-198
Evaluation of Changes in Leukocyte Surface Markers in the Early Diagnosis of Late-Onset Neonatal Sepsis
Objective This study aimed to evaluate the cluster of differentiation (CD)64, CD16, CD11b, CD63 human leukocyte antigen-DR (HLA-DR), and CD62L leukocyte surface marker abnormalities using flow cytometry in the early diagnosis of late-onset neonatal sepsis. Methods Forty-four neonates were included in this study. Of them, 22 neonates with clinical late-onset neonatal sepsis were included in the study group, and the remaining 22 neonates without sepsis were considered the control group. Complete sepsis screening was performed. Additionally, monocyte and neutrophil surfaces marker were examined using flow cytometry. Results The expression of the leukocyte surface markers CD16 and CD64 on monocytes and neutrophils was significantly higher in the study group than in the control group (p < 0.05), while the CD63, CD62L, CD11b, and HLA-DR levels were similar to those in the control group (p > 0.05). Furthermore, receiver operating characteristic curve analysis indicated that neutrophil CD64 (nCD64) is a diagnostic marker for neonatal sepsis, with an area under the curve of 0.901. The CD64 and CD16, which are the respective leukocyte surface markers on neutrophils and monocytes, are useful tests in the early diagnosis of late-onset neonatal sepsis. Conclusion In addition to acute phase proteins, cell surface antigens such as CD16 and more specifically CD64 should be used in routine investigations for the early diagnosis of late-onset neonatal sepsis. Such use in combination with acute phase reactants can improve diagnostic accuracy.
- Open Access
- 1 August 2018
- Published by Springer Nature in BMC Pediatrics
- Vol. 18 (1) , 253
The cut-off levels of procalcitonin and C-reactive protein and the kinetics of mean platelet volume in preterm neonates with sepsis
Sepsis is a leading cause of morbidity and mortality among newborns. C-reactive protein (CRP) and procalcitonin (PCT) have some limitations in the diagnosis of preterm neonatal sepsis. In this study, the cut-offs of PCT and CRP, and the efficacy of mean platelet volume (MPV) were investigated. We identified key demographic details and compared laboratory values between preterm infants with early onset and late onset neonatal sepsis (EONS/LONS) retrospectively. Blood samples were collected within the first few hours of the onset of clinical sepsis (CRP 1, PCT 1, MPV 1) and were repeated after 24 h (CRP 2, PCT 2, MPV 2). The optimal cut-offs for CRP, PCT and MPV were determined using receiver operating characteristic (ROC) analysis. Furthermore, pairwise comparisons of ROC curves were made to evaluate the performances of these tests. In EONS, the cut-off of CRP 1 was 2.6 mg/L, the sensitivity, specificity, PPV and NPV were 80.6, 83.0, 67.5 and 90.7%, respectively (p < 0.001). At a PCT 1 cut-off of 1.1 ng/mL, the sensitivity, specificity, PPV and NPV were 78.6, 81.2, 64.7 and 89.6%, respectively (p < 0.001). The sensitivity, specificity, PPV, and NPV of the CRP 1 cut-off of 3.6 mg/L for LONS were 78.3, 87.4, 74.8, and 89.4%, respectively. At a PCT 1 cut-off of 5.2 ng/mL, the sensitivity, specificity, PPV and NPV were 58.5, 95.5, 86.1, and 82.9% respectively. For proven sepsis, the cut-off of CRP 1 was 7.0 mg/L with a 76.5% sensitivity, 98.2% specificity, 94.9% PPV and 90.5% NPV (p < 0.001). At a PCT 1 cut-off of 1.36 ng/mL, the sensitivity, specificity, PPV and NPV were 90.8, 83.4, 70.6 and 94.4%, respectively (p < 0.001). In each subgroup, other than EONS, the performances of CRP 1 and PCT 1 measurements were found to be statistically higher than MPV 1. CRP 2 cut-off levels of LONS group and proven sepsis group were found to be lower than the initial values. Optimal cut-off levels of CRP 1 and PCT 1 may differ in preterm sepsis subgroups. The diagnostic performances of CRP 1 and PCT 1 didn’t differ however, they were more efficacious than MPV.
- 1 August 2018
- Published by Springer Nature in BMC Pediatrics
- Vol. 18 (1) , 253
Open AccessThe cut-off levels of procalcitonin and C-reactive protein and the kinetics of mean platelet volume in preterm neonates with sepsis
Sepsis is a leading cause of morbidity and mortality among newborns. C-reactive protein (CRP) and procalcitonin (PCT) have some limitations in the diagnosis of preterm neonatal sepsis. In this study, the cut-offs of PCT and CRP, and the efficacy of mean platelet volume (MPV) were investigated. We identified key demographic details and compared laboratory values between preterm infants with early onset and late onset neonatal sepsis (EONS/LONS) retrospectively. Blood samples were collected within the first few hours of the onset of clinical sepsis (CRP 1, PCT 1, MPV 1) and were repeated after 24 h (CRP 2, PCT 2, MPV 2). The optimal cut-offs for CRP, PCT and MPV were determined using receiver operating characteristic (ROC) analysis. Furthermore, pairwise comparisons of ROC curves were made to evaluate the performances of these tests. In EONS, the cut-off of CRP 1 was 2.6 mg/L, the sensitivity, specificity, PPV and NPV were 80.6, 83.0, 67.5 and 90.7%, respectively (p < 0.001). At a PCT 1 cut-off of 1.1 ng/mL, the sensitivity, specificity, PPV and NPV were 78.6, 81.2, 64.7 and 89.6%, respectively (p < 0.001). The sensitivity, specificity, PPV, and NPV of the CRP 1 cut-off of 3.6 mg/L for LONS were 78.3, 87.4, 74.8, and 89.4%, respectively. At a PCT 1 cut-off of 5.2 ng/mL, the sensitivity, specificity, PPV and NPV were 58.5, 95.5, 86.1, and 82.9% respectively. For proven sepsis, the cut-off of CRP 1 was 7.0 mg/L with a 76.5% sensitivity, 98.2% specificity, 94.9% PPV and 90.5% NPV (p < 0.001). At a PCT 1 cut-off of 1.36 ng/mL, the sensitivity, specificity, PPV and NPV were 90.8, 83.4, 70.6 and 94.4%, respectively (p < 0.001). In each subgroup, other than EONS, the performances of CRP 1 and PCT 1 measurements were found to be statistically higher than MPV 1. CRP 2 cut-off levels of LONS group and proven sepsis group were found to be lower than the initial values. Optimal cut-off levels of CRP 1 and PCT 1 may differ in preterm sepsis subgroups. The diagnostic performances of CRP 1 and PCT 1 didn’t differ however, they were more efficacious than MPV.
- 1 November 2011
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 46 (11) , 2096-2100
Total oxidant status and oxidative stress are increased in infants with necrotizing enterocolitis
- 1 November 2011
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 46 (11) , 2096-2100
Total oxidant status and oxidative stress are increased in infants with necrotizing enterocolitis
- 1 October 2011
- Published by Elsevier in Early Human Development
- Vol. 87 (10) , 659-661
Serum intestinal fatty acid binding protein level for early diagnosis and prediction of severity of necrotizing enterocolitis
- 1 October 2011
- Published by Elsevier in Early Human Development
- Vol. 87 (10) , 659-661
Serum intestinal fatty acid binding protein level for early diagnosis and prediction of severity of necrotizing enterocolitis
- 10 December 2010
- Published by Taylor & Francis in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 24 (9) , 1124-1127
Mannose-binding lectin codon 54 gene polymorphism in relation to risk of nosocomial invasive fungal infection in preterm neonates in the neonatal intensive care unit
Objective. Preterm neonates are susceptible to infection due to a combination of sub-optimal immunity and increased exposure to invasive organisms. Invasive fungal infections are associated with significant morbidity and mortality among preterm infants cared for in the neonatal intensive care unit (NICU). Mannose-binding lectin (MBL) is a component of the innate immune system, which may be especially important in the neonatal setting. The objective of this study was to investigate the presence of any association between MBL gene polymorphism and nosocomial invasive fungal infection in preterm neonates. Methods. Codon 54 (B allele) polymorphism in exon 1 of the MBL gene was investigated in 31 patients diagnosed as nosocomial invasive fungal infection and 30 control preterm neonates. Results. AB genotype was determined in 26% and 30% of patient and control groups, respectively, and the difference was not statistically significant. AA genotype was determined in 74% of the patient group and in 67% of the control group, and the difference was not statistically significant. B allele frequency was not different significantly in the patient group (13%) compared to the control group (18%). Conclusions. In our study, no relationship was found between MBL codon 54 gene polymorphism and the risk of nosocomial invasive fungal infection in preterm neonates in NICU.
- 10 December 2010
- Published by Taylor & Francis in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 24 (9) , 1124-1127
Mannose-binding lectin codon 54 gene polymorphism in relation to risk of nosocomial invasive fungal infection in preterm neonates in the neonatal intensive care unit
Objective. Preterm neonates are susceptible to infection due to a combination of sub-optimal immunity and increased exposure to invasive organisms. Invasive fungal infections are associated with significant morbidity and mortality among preterm infants cared for in the neonatal intensive care unit (NICU). Mannose-binding lectin (MBL) is a component of the innate immune system, which may be especially important in the neonatal setting. The objective of this study was to investigate the presence of any association between MBL gene polymorphism and nosocomial invasive fungal infection in preterm neonates. Methods. Codon 54 (B allele) polymorphism in exon 1 of the MBL gene was investigated in 31 patients diagnosed as nosocomial invasive fungal infection and 30 control preterm neonates. Results. AB genotype was determined in 26% and 30% of patient and control groups, respectively, and the difference was not statistically significant. AA genotype was determined in 74% of the patient group and in 67% of the control group, and the difference was not statistically significant. B allele frequency was not different significantly in the patient group (13%) compared to the control group (18%). Conclusions. In our study, no relationship was found between MBL codon 54 gene polymorphism and the risk of nosocomial invasive fungal infection in preterm neonates in NICU.
- 30 November 2010
- Published by Elsevier in Early Human Development
- Vol. 86, S93-S94
PP-190. Screening for retinopathy of prematurity in a large tertiary neonatal intensive care unit in Turkey: Frequency and risk factors
- 30 November 2010
- Published by Elsevier in Early Human Development
- Vol. 86, S93-S94
PP-190. Screening for retinopathy of prematurity in a large tertiary neonatal intensive care unit in Turkey: Frequency and risk factors
- 30 November 2010
- Published by Elsevier in Early Human Development
- Vol. 86, S92-S93
PP-187. Poor weight gain adjusted for birth weight and gestational age as a predictor of severe ROP in VLBW infants
- 30 November 2010
- Published by Elsevier in Early Human Development
- Vol. 86, S92-S93
PP-187. Poor weight gain adjusted for birth weight and gestational age as a predictor of severe ROP in VLBW infants
- 21 July 2010
- Published by BMJ in Archives of Disease in Childhood - Fetal and Neonatal Edition
- Vol. 96 (3) , F164-F168
Randomised controlled trial of prophylactic fluconazole versus nystatin for the prevention of fungal colonisation and invasive fungal infection in very low birth weight infants
Background Invasive fungal infections are a major cause of morbidity and mortality in preterm infants. The authors conducted the first prospective, randomised controlled trial of nystatin compared with fluconazole for the prevention of fungal colonisation and invasive fungal infection in very low birth weight (VLBW) neonates. Methods During a 12-month period, all VLBW neonates were assigned randomly to receive nystatin (1 ml suspension, 100 000 U/ml, every 8 h), fluconazole (3 mg/kg body weight, every third day) or placebo from birth until day 30 of life (day 45 for neonates weighing Results During the study period, 278 infants (fluconazole group, n=93; nystatin group, n=94; control group, n=91) weighing Conclusions Prophylactic nystatin and fluconazole reduce the incidence of colonisation and invasive fungal infection in VLBW neonates. The authors believe that nystatin is an alternative to fluconazole, because nystatin is safe, inexpensive, well tolerated and effective.
- 21 July 2010
- Published by BMJ in Archives of Disease in Childhood - Fetal and Neonatal Edition
- Vol. 96 (3) , F164-F168
Randomised controlled trial of prophylactic fluconazole versus nystatin for the prevention of fungal colonisation and invasive fungal infection in very low birth weight infants
Background Invasive fungal infections are a major cause of morbidity and mortality in preterm infants. The authors conducted the first prospective, randomised controlled trial of nystatin compared with fluconazole for the prevention of fungal colonisation and invasive fungal infection in very low birth weight (VLBW) neonates. Methods During a 12-month period, all VLBW neonates were assigned randomly to receive nystatin (1 ml suspension, 100 000 U/ml, every 8 h), fluconazole (3 mg/kg body weight, every third day) or placebo from birth until day 30 of life (day 45 for neonates weighing Results During the study period, 278 infants (fluconazole group, n=93; nystatin group, n=94; control group, n=91) weighing Conclusions Prophylactic nystatin and fluconazole reduce the incidence of colonisation and invasive fungal infection in VLBW neonates. The authors believe that nystatin is an alternative to fluconazole, because nystatin is safe, inexpensive, well tolerated and effective.